|
TMX3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.73400000000168E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.79069999999282E-05 |
| Normal-vs-Stage2 |
7.802800E-03 |
| Normal-vs-Stage3 |
8.811500E-04 |
| Normal-vs-Stage4 |
4.162300E-03 |
| Stage1-vs-Stage2 |
6.632800E-01 |
| Stage1-vs-Stage3 |
4.097200E-01 |
| Stage1-vs-Stage4 |
2.189000E-01 |
| Stage2-vs-Stage3 |
4.293400E-01 |
| Stage2-vs-Stage4 |
3.044400E-01 |
| Stage3-vs-Stage4 |
6.527400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.50670000000197E-05 |
| Normal-vs-AfricanAmerican |
3.373700E-02 |
| Normal-vs-Asian |
8.387700E-02 |
| Caucasian-vs-AfricanAmerican |
6.781900E-02 |
| Caucasian-vs-Asian |
9.148600E-01 |
| AfricanAmerican-vs-Asian |
4.062800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.557250E-04 |
| Normal-vs-Female |
7.82990000000039E-05 |
| Male-vs-Female |
9.549000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.218300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.54924999999917E-05 |
| Normal-vs-Age(61-80Yrs) |
1.811720E-04 |
| Normal-vs-Age(81-100Yrs) |
1.890420E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.200400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.980800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.754000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.379600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.367400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.823800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.039400E-03 |
| Normal-vs-Grade 2 |
4.25400000003684E-07 |
| Normal-vs-Grade 3 |
8.244500E-04 |
| Normal-vs-Grade 4 |
2.825900E-02 |
| Grade 1-vs-Grade 2 |
5.930800E-01 |
| Grade 1-vs-Grade 3 |
4.690100E-02 |
| Grade 1-vs-Grade 4 |
5.590300E-02 |
| Grade 2-vs-Grade 3 |
3.724000E-03 |
| Grade 2-vs-Grade 4 |
5.677500E-03 |
| Grade 3-vs-Grade 4 |
4.789200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.58469999531764E-08 |
| Normal-vs-ccB subtype |
1.217440E-03 |
| ccA subtype-vs-ccB subtype |
1.770360E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.51690000000216E-05 |
| Normal-vs-N1 |
9.224400E-02 |
| N0-vs-N1 |
7.395800E-01 |
|
|
